Profil GmbH is a full service CRO based in Germany and certified according to ISO 9001 and 13485. Profil was founded in 1999 as a spin-off of an academic study group at the department of metabolic diseases and nutrition at University of Düsseldorf. Unlike other CROs, we focus our clinical research on diabetes and related diseases. Because of our professional setup with a huge recruitment database (>13,000 people with diabetes), a dedicated regulatory department, a fully GMP certified pharmacy and two in-house clinics (in Neuss and Mainz) with a total of 80+ beds we are able to reliably perform clinical studies within agreed timelines. We have implemented numerous sophisticated methods allowing characterization of pharmacodynamic effects already in early phase trials. Our key competence comprises the performance of glucose clamp studies often combined with isotope dilution techniques and muscle or fat biopsies. We have been involved in the development of all major anti-diabetic compounds. But we are much more than a conventional CRO. We offer a unique combination of regulatory and scientific know-how and expertise. Our portfolio of complex experimental methods is unrivalled within both contract and academic research. Our scientific experts are internationally acknowledged for their contributions in the fields of diabetes, pharmacology, obesity, prediabetes, cardiology, nutrition, endocrinology and medical technology. We have published more than 360 papers in peer-reviewed journals and regularly present our research at international scientific meetings. With our scientific expertise we optimise the design of a study and select the right combination of research methods. The results of our clinical studies deliver the answers needed for the further development of a compound. For more information about Profil, please visit www.profil.com.